|
人TIGIT / CD226 Jurkat 过表达细胞系 Human TIGIT / CD226 Jurkat Cell Line
靶点信息

Target: T cell immunoreceptor with Ig and ITIM domains Alias: DKFZp667A205, FLJ39873, VSIG9, VSTM3
TIGIT(T 细胞免疫球蛋白和 ITIM 结构域蛋白)是一种在 T 细胞和 NK 细胞表面表达的免疫检查点抑制性受体,通过与 CD155(PVR)结合,抑制免疫细胞活化,在肿瘤免疫逃逸中发挥重要作用。 |
产品信息
人TIGIT / CD226 Jurkat 过表达细胞系是一种重组细胞系,经工程化改造后可稳定表达细胞表面人 TIGIT 蛋白,广泛用于机制研究、高通量筛选、药物靶标验证及其他相关领域。
| Host Cell | Jurkat | Gene | TIGIT / CD226 | | Size | >5x10^6 cells per vial | Storage | Liquid nitrogen | | Species | Human | Shipment | Dry Ice | | Stability | Validated for at least 10 passages | | Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. | | Applications | Widely used in mechanisms study, high-throughput screening, drug target validation and others. | | Revival | After retrieving the cells from the liquid nitrogen tank, rapidly thaw them in a 37°C water bath. Transfer contents into a tube with pre-warmed media. Centrifuge cells and seed into a 25 cm^2 flask containing pre-warmed media. |

产品验证

备注:图片仅供参考,具体验证数据以购买时交付批次为准
|